Ee Carolyn C, Al-Kanini Ieman, Armour Mike, Piya Milan K, McMorrow Rita, Rao Vibhuti S, Naidoo Dhevaksha, Metzendorf Maria-Inti, Kroeger Cynthia M, Sabag Angelo
NICM Health Research Institute, Western Sydney University, Sydney, Australia.
School of Medicine, Western Sydney University, Sydney, Australia.
Integr Med Res. 2025 Jun;14(2):101138. doi: 10.1016/j.imr.2025.101138. Epub 2025 Mar 20.
Type 2 diabetes mellitus (T2DM) can lead to macro- and microvascular complications. Mindfulness-based interventions (MBIs) may improve metabolic and psychological health in individuals with T2DM. We aimed to assess the efficacy of MBIs for management of T2DM.
We searched five databases and two trial registries using a comprehensive search strategy developed by a multidisciplinary team including an information scientist. We included randomised controlled trials (RCTs) investigating MBIs for important clinical outcomes including psychological outcomes, quality of life, glycaemic control and cardiovascular risk factors in adults with T2DM. Where possible, random effects meta-analyses were conducted. The Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach was used to assess certainty of the evidence.
We included 31 RCTs (2337 participants: 1107 intervention, 1230 control). We found very low certainty evidence that MBIs may reduce stress (standardized mean difference (SMD) -1.01, confidence interval (CI) -1.91 to -0.20, 8 trials, = 528), depression (SMD -1.26, CI -2.08 to -0.43; 7 trials, = 570) and anxiety (SMD -0.67, CI -1.27 to -0.08; 4 studies, = 255) at end of treatment compared to waitlist control/usual care. MBIs may have a small effect on HbA1c and systolic/diastolic blood pressure at end of treatment compared to waitlist control/usual care (HbA1c mean difference (MD) -0.44, 95 % CI -0.71 to -0.17, 9 trials, = 734; low certainty evidence). There was very low certainty evidence that MBIs + lifestyle may have no effect on HbA1c or body weight compared to lifestyle alone.
MBIs may have clinical benefits (particularly psychological) for adults with T2DM, but lack of certainty in the evidence precludes clinical recommendations.
Cochrane Database of Systematic Reviews, DOI: 10.1002/14651858.CD014881.
2型糖尿病(T2DM)可导致大血管和微血管并发症。基于正念的干预措施(MBIs)可能改善T2DM患者的代谢和心理健康。我们旨在评估MBIs对T2DM管理的疗效。
我们使用由包括信息科学家在内的多学科团队制定的综合检索策略,检索了五个数据库和两个试验注册库。我们纳入了随机对照试验(RCTs),这些试验研究了MBIs对重要临床结局的影响,包括心理结局、生活质量、血糖控制以及T2DM成年患者的心血管危险因素。在可能的情况下,进行随机效应荟萃分析。采用推荐分级、评估、制定和评价(GRADE)方法评估证据的确定性。
我们纳入了31项RCTs(2337名参与者:1107名干预组,1230名对照组)。我们发现证据确定性很低,与等待名单对照/常规护理相比,MBIs在治疗结束时可能减轻压力(标准化均数差(SMD)-1.01,置信区间(CI)-1.91至-0.20,8项试验,n = 528)、抑郁(SMD -1.26,CI -2.08至-0.43;7项试验,n = 570)和焦虑(SMD -0.67,CI -1.27至-0.08;4项研究,n = 255)。与等待名单对照/常规护理相比,MBIs在治疗结束时可能对糖化血红蛋白(HbA1c)和收缩压/舒张压有较小影响(HbA1c平均差(MD)-0.44,95%CI -0.71至-0.17,9项试验,n = 734;证据确定性低)。证据确定性很低,表明与单纯生活方式干预相比,MBIs + 生活方式干预可能对HbA1c或体重没有影响。
MBIs可能对T2DM成年患者有临床益处(尤其是心理方面),但证据缺乏确定性,无法给出临床推荐。
Cochrane系统评价数据库,DOI:10.1002/14651858.CD014881。